NCT00844480View on ClinicalTrials.gov

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss

PHASE2TerminatedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions

Bone Loss

Interventions

DRUG

zoledronic acid

zoledronic acid, 5mg, iv

DRUG

placebo

iv

Trial Locations (1)

60611

Rehabilitation Institute of Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Thomas J. Schnitzer

OTHER